Navigation Links
Most Teachers Favor Inclusion for Autistic Students
Date:5/11/2011

WEDNESDAY, May 11 (HealthDay News) -- The majority of general education teachers support the notion of including autistic children in a regular classroom environment, a small new survey suggests.

Overall, the eight general education teachers surveyed expressed positive views of inclusion for children with autism, but they felt additional resources would help ensure success in a mainstream classroom.

Survey co-authors P. Rosen and E. Rotheram-Fuller, of Temple University, and D. S. Mandell, from the University of Pennsylvania School of Medicine, are scheduled to present the findings Wednesday at the International Meeting for Autism Research in San Diego.

The teachers surveyed worked in a single, large urban school district. Each had between one and four students with autism already present in classrooms that catered to an average of 25 students. The majority of the autistic students spent at least half a day enrolled in a general education setting, according to a meeting news release.

On average the teachers had more than 10 years of experience, although specific work with autistic students ranged from none to 15 years.

The preliminary results revealed that all the teachers shared a positive perspective on including autistic children in an otherwise standard classroom setting.

Doing so was completely appropriate for 44 percent of students, and somewhat appropriate for 33 percent of students, they said. And as a whole, those surveyed indicated that they felt most of the autistic students (66 percent) would do well to remain in their current classroom situation.

However, for 22 percent of students, inclusion was considered somewhat inappropriate, and for one-third of students, a different, more restrictive environment would be better, the teachers said.

Regardless of their views, the teachers generally expressed confidence in their ability to handle autistic students, w
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Siemens Awards for Advanced Placement Honor Top U.S. Science and Math Students and Teachers
2. Omega Institute Reopens With More Teachers Than Ever
3. Better Teachers Make for Stronger Young Readers
4. More than 60 percent of teachers have voice problems
5. Teachers-based intervention provides stress resistance in war-exposed children
6. Safety data favor norepinephrine over dopamine for shock
7. Go with Your Gut and Boost your Immune System with America's Favorite Fruit
8. Study shows partial lung removal favorable over full removal as treatment for lung cancer
9. Tapping away desire for those favorite foods and snacks
10. Patients, clinicians favor disclosure of financial ties to industry
11. Favorpals.com's Releases New Platform for Free Online Bartering Network
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Most Teachers Favor Inclusion for Autistic Students
(Date:7/29/2014)... 29, 2014 Healthcare staffing agency ... Nurses of Tomorrow Scholarship Competition winners:, ... NV ,     Racheal D., Freshman, Cerritos College ... Houston Community College in Houston, TX ... Medical Solutions hosts the Nurses of Tomorrow Scholarship ...
(Date:7/29/2014)... 29, 2014 Catalent Pharma Solutions, ... advanced delivery technologies for pharmaceutical, biologic, and consumer ... R&D Director and US Platform Leader of Pharmaceutical ... Drugs with Lipid-Based Formulations using Soft Capsule Delivery ... the Japan Society of Drug Delivery Systems (30-31 ...
(Date:7/29/2014)... The Affordable Care Act has created a dramatic ... show that over 400 hospitals probably won’t survive this ... that great hospitals use to survive the threat increases ... secret? Debriefing - the simple process of systematically offering ... operational event. Debriefing is a standard procedure in military ...
(Date:7/29/2014)... Dennis Thompson HealthDay Reporter , MONDAY, ... three years longer than people who don,t run, according to new ... that it appears that you can reap this benefit even if ... 15-year study suggests. "People may not need to run ... an assistant professor of kinesiology at Iowa State University. "I hope ...
(Date:7/29/2014)... Kelly and Zhi Sheng , assistant professors ... recently received a grant from the Commonwealth Health ... effort that may lead to new treatment approaches. , ... , The grant will fund a two-year project to ... the BRCA1 gene. This type of cancer often has ...
Breaking Medicine News(10 mins):Health News:Medical Solutions Announces Nurses of Tomorrow Scholarship Winners 2Health News:Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems 2Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 2Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 3Health News:Running Could Add 3 Years to Your Lifespan 2Health News:Running Could Add 3 Years to Your Lifespan 3Health News:Scientists to study hereditary breast cancer to find BRCA1 treatment 2
... Better ... Treatment Options, WASHINGTON, Nov. 2 Today, the ... for interventional cardiology, announced the,launch of Seconds Count, a ... an authoritative resource about cardiovascular disease and,treatment. The program ...
... AMED or the "Company"), one of America,s leading home ... and,Chief Operating Officer, and Dale E. Redman, Chief Financial ... Annual Healthcare Conference in,New York on Tuesday, November 6, ... Eastern time. The audio,presentation will be webcast live and ...
... inhibitor demonstrates >99% mean decrease in HCV RNA ... with no serious adverse events-, ... the results of a 14-day Phase 1 multiple ascending,dose monotherapy study ... study, being presented as a "late-breaker" abstract at,the 58th Annual Meeting ...
... IDM Pharma, Inc.,(Nasdaq: IDMI ) today announced ... mifamurtide (L-MTP-PE) in patients,with lung metastases as a result ... bone tumor that typically affects children and young,adults. The ... is,safe, well-tolerated and exhibited signs of disease control. ...
... Medical,s blood loss detection,device for monitoring venous needle ... available for sale in the United States. The ... the world,s,first such device. Having met Europe,s rigorous ... granted CE approval. With the FDA,s approval,Redsense is ...
... Statement by James Wagoner on the $28 ... Nov. 1 The following is a,statement ... increase in abstinence-only,program funding:, Today, we ... committee report includes the full $28 million,increase ...
Cached Medicine News:Health News:New Web Site Helps Patients Navigate Heart Disease Treatment Options 2Health News:New Web Site Helps Patients Navigate Heart Disease Treatment Options 3Health News:Amedisys to Present at 2007 CIBC Healthcare Conference in New York 2Health News:Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C 2Health News:Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C 3Health News:Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C 4Health News:Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C 5Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 2Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 3Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 4Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 5Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 6Health News:IDM Pharma Announces Data Presentation From Mifamurtide (L-MTP-PE) Compassionate Use Program 7Health News:Redsense Medical Receives FDA Approval for Blood Loss Detection Device 2Health News:Redsense Medical Receives FDA Approval for Blood Loss Detection Device 3Health News:Democrats Cave on Sex Education - Again 2
(Date:7/29/2014)... 2014 China Biologic Products, Inc. (NASDAQ: CBPO, ... plasma-based biopharmaceutical company in China , ... quarter 2014 financial results on Tuesday, August 5, 2014 ... management will hold a conference call at 8:00 a.m. ... p.m., Beijing Time on August 6, 2014, to discuss ...
(Date:7/29/2014)... 29, 2014 , Next ... development program has commenced , TPM®/Oxycodone Phase ... during Q4 2014 , TPM®/Oxymorphone Phase 2 ... 1H 2015 Australian drug delivery company, Phosphagenics ... transdermal patch programs after its recent announcement of a $19.2 million ...
(Date:7/29/2014)...   , First patient ... efficacy and safety of MSB0010718C in patients with metastatic Merkel ... aggressive skin cancer lacking effective treatments   MSB0010718C is ... clinical trial for the treatment of solid tumors that aims ... a subsidiary of Merck KGaA, Darmstadt, Germany ...
Breaking Medicine Technology:China Biologic to Report Second Quarter 2014 Financial Results 2China Biologic to Report Second Quarter 2014 Financial Results 3Phosphagenics Provides Update on Opioid Patch Program 2Phosphagenics Provides Update on Opioid Patch Program 3Phosphagenics Provides Update on Opioid Patch Program 4Phosphagenics Provides Update on Opioid Patch Program 5Phosphagenics Provides Update on Opioid Patch Program 6EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5
... /Xinhua-PRNewswire/ -- NeuroAid(TM) is the first,natural compound to ... on stroke,recovery starting in the acute stage. ... trial to evaluate the efficacy of NeuroAid(TM) in ... with treatment starting within 48 hours of a ...
... 26 Rcadia Medical Imaging, Ltd.,developer of novel ... Food and Drug Administration (FDA) clearance to market,its ... triaging patients for,coronary artery disease (CAD). The new ... human intervention and automatic detection of,pathologies in the ...
Cached Medicine Technology:International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery 2International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery 3International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery 4Rcadia's COR Analyzer Family of Products Receives Second FDA Clearance 2
A custom blend for Applied Biosystems by FMC. Designed specifically for the electrophoresis of PCR products....
... for screening donors on the PK7200 Automated ... CMV antigen attached to a gelatin particle ... and specificity of the CMV assay as ... respectively. The use of a gelatin particle ...
The Ortho AutoVue System is an automated immunohematology testing system used for blood typing, antibody screening and compatibility testing using Ortho BioVue System cassettes....
... designed for medium to ... centers and reference laboratories ... antibody screening. It will ... functions including blood group ...
Medicine Products: